A clinical case of drug-induced arterial hypertension caused by glycyrrhizic acid

Oxana N. Antropova , Irina V. Osipova , Svetlana B. Silkina , Lolita A. Obrazcova

Journal of Clinical Practice ›› 2023, Vol. 14 ›› Issue (2) : 120 -124.

PDF
Journal of Clinical Practice ›› 2023, Vol. 14 ›› Issue (2) : 120 -124. DOI: 10.17816/clinpract138628
Case reports
research-article

A clinical case of drug-induced arterial hypertension caused by glycyrrhizic acid

Author information +
History +
PDF

Abstract

Background: In clinical practice, drug-induced arterial hypertension (AH) often remains undiagnosed, since the identification of an ethical disease in this form of AH avoids the initiation of antihypertensive therapy. A critical part in the differential diagnosis of hypertension and planning of long-term strategies for managing a patient requires a thorough study of the properties of the drugs taken and the pathophysiological mechanisms that depend on the increase in high blood pressure against the background of taking one or another substance.

Clinical case description: Assumption of pregnancy in a random 57-year-old Caucasian female patient with AH syndrome and history of AD crisis during the year. Against the background of two-component antihypertensive therapy, indapamide 2.5 mg + telmisartan 80 mg, increased blood pressure. From the anamnesis of life, it is noteworthy that the patient should keep records with a hepatologist; with a diagnosis of chronic viral hepatitis C with moderate activity, she takes Phosphogliv. Physical examination confirmed the presence of grade 2 hypertension; no signs of target organ detection were found. Laboratory and instrumental research showed cytolytic syndrome of minimal activity (AST, 74.8 U/l; ALT, 60.5 U/l), hypokalemia (K+ 2.1 mmol/l), unknown etiology, aldosterone within the normal range, metanephrine (80.4 pg/ml at a rate of <64 pg/ml), and normetanephrine (276 pg/ml at a rate of <176 pg/ml) in blood plasma are increased. MSCT of the kidneys and adrenal glands revealed no enlarged formations. Drug-induced arterial hypertension was clinically diagnosed. Concomitant diseases: Chronic viral hepatitis C, moderate activity. Varicose veins, venous infection of the extremities. Dynamics and outcome. After the abolition of glycyrrhizic acid, blood pressure and potassium levels in the blood plasma returned to normal, which is not recommended to take antihypertensive drugs.

Conclusion: An exceptional clinical situation is a pronounced manifestation of a rare side effect of glycyrrhizic acid in the form of drug-induced hypertension.

Keywords

drug-induced arterial hypertension / symptomatic arterial hypertension / glycyrrhizic acid

Cite this article

Download citation ▾
Oxana N. Antropova, Irina V. Osipova, Svetlana B. Silkina, Lolita A. Obrazcova. A clinical case of drug-induced arterial hypertension caused by glycyrrhizic acid. Journal of Clinical Practice, 2023, 14(2): 120-124 DOI:10.17816/clinpract138628

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

96

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/